Activation and protein kinase C-dependent nuclear accumulation of ERK in differentiating human neuroblastoma cells

Experimental Cell Research

Volumn 256, Issue 2, 2000, Pages 454-467

  Olsson, Anna Karin ^a   Vadhammar, Karin ^a   Nånberg, Eewa ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Differentiation; Extracellular signal regulated kinase; Neuroblastoma; NGF; Protein kinase C

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN C FOS; PROTEIN KINASE C;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; PRIORITY JOURNAL; SERUM RESPONSIVE ELEMENT; TRANSACTIVATION;

EID: 0034193123     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4843     Document Type: Article

References (80)

1. Anderson D. J. Molecular control of cell fate in the neural crest: The sympathoadrenal lineage. Annu. Rev. Neurosci. 16:1993;129-158.
2. Lillen L. Neural development: Instructions for neural diversity. Curr. Biol. 7:1997;R168-R171.
3. Greene L. A., Tischler A. S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA. 73:1976;2424-2428.
4. Greene L. A., Tischler A. S. PC12 phaeochromocytoma cultures in neurobiological research. Adv. Cell. Neurobiol. 3:1982;373-414.
5. Kaplan D. R., Stephens R. M. Neurotrophin signal transduction by the Trk receptor. J. Neurobiol. 25:1994;1404-1417.
6. Bar-Sagi D., Feramisco J. R. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell. 42:1985;841-848.
7. Szeberenyi J., Cai H., Cooper G. M. Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells. Mol. Cell. Biol. 10:1990;5324-5332.
8. Wood K. W., Qi H., D'Arcangelo G., Armstrong R. C., Roberts T. M., Halegoua S. The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells: A potential role for cellular raf kinases in neuronal growth factor signal transduction. Proc. Natl. Acad. Sci. USA. 90:1993;5016-5020.
9. Cowley S., Paterson H., Kemp P., Marshall C. J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 77:1994;841-852.
10. Fukuda M., Gotoh Y., Tachibana T., Dell K., Hattori S. Induction of neurite outgrowth by MAP kinase in PC12 cells. Oncogene. 11:1995;239-244.
11. Robinson M. J., Stippec S. A., Goldsmith E., White M. A., Cobb M. H. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr. Biol. 8:1998;1141-1150.
12. Qui M., Green S. PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron. 9:1992;705-717.
13. Traverse S., Gomez N., Paterson H., Marshall C., Cohen P. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288:1992;351-355.
14. Dikic I., Schlessinger J., Lax I. PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation. Curr. Biol. 4:1994;702-708.
15. Traverse S., Seedorf K., Paterson H., Marshall C. J., Cohen P., Ullrich A. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr. Biol. 4:1994;694-701.
16. Marshall C. J. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
17. Biedler J. L., Helson L., Spengler B. A. Morphology and growth, tumorigenicity and cytogenetics of human neuroblastoma cells in continous culture. Cancer Res. 33:1973;2643-2652.
18. Tanaka T., Sugimoto T., Sawada T. Prognostic discrimination among neuroblastomas according to Ha-ras/trk A gene expression. Cancer. 83:1998;1626-1633.
19. Brodeur G. M. Molecular basis for heterogeneity in human neuroblastomas. Eur. J. Cancer. 31A:1995;505-510.
20. Påahlman S., Odelstad L., Larsson E., Grotte G., Nilsson K. Phenotypic changes of neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate. Int. J. Cancer. 28:1981;583-589.
21. Påhlman S., Ruusala A.-I., Abrahamsson L., Odelstad L., Nilsson K. Kinetics and concentration effects of TPA-induced differentiation of cultured human neuroblastoma cells. Cell Differ. 12:1983;165-170.
22. Påhlman S., Meyerson G., Lindgren E., Schalling M., Johansson I. Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation. Proc. Natl. Acad. Sci. USA. 88:1991;9994-9998.
23. Påhlman S., Johansson I., Westermark B., Nister M. Platelet-derived growth factor potentiates phorbol ester-induced neuronal differentiation of human neuroblastoma cells. Cell Growth Differ. 3:1992;783-790.
24. Lavenius E., Parrow V., Nånberg E., Påhlman S. Basic FGF and IGF-1 promote differentiation of human SH-SY5Y neuroblastoma cells in culture. Growth Factors. 10:1994;29-39.
25. Lavenius E., Gestblom C., Johansson I., Nånberg E., Påhlman S. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor. Cell Growth Differ. 6:1995;727-736.
26. Poluha W., Poluha D. K., Ross A. H. TrkA neurogenic receptor regulates differentiation of neuroblastoma cells. Oncogene. 10:1995;185-189.
27. Parrow V., Nånberg E., Heikkilä J., Hammerling U., Påhlman S. Protein kinase C remains functionally active during TPA induced neuronal differentiation of SH-SY5Y human neuroblastoma cells. J. Cell. Physiol. 152:1992;536-544.
28. Parrow V., Fagerström S., Meyerson G., Nånberg E., Påhlman S. Protein kinase C-α and -ε are enriched in growth cones of differentiating SH-SY5Y human neuroblastoma cells. J. Neurosci. Res. 41:1995;782-791.
29. Fagerström S., Påhlman S., Gestblom C., Nånberg E. Protein kinase C-ε is implicated in neurite outgrowth in differentiating human neuroblastoma cells. Cell Growth Differ. 7:1996;775-785.
30. cas in differentiating neuroblastoma cells. J. Biol. Chem. 273:1998;2336-2343.
31. Zeidman R., Löfgren B., Påhlman S., Larsson C. PKCε, via its regulatory domain and independently of its catalytic domain, induces neurite-like processes in neuroblastoma cells. J. Cell Biol. 145:1999;713-726.
32. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F., Duhamel L., Charon D., Kirilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:1991;15771-15781.
33. Birchall A. M., Bishop J., Bradshaw D., Cline A., Coffey J., Elliott L. H., Gibson V. M., Greenham A., Hallam T. J., Harris W., Hill C. H., Hutchings A., Lamont A. G., Lawton G., Lewis E. J., Maw A., Nixon J. S., Pole D., Wadsworth J., Wilkinson S. E. Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation. J. Pharmacol. Exp. Ther. 268:1994;922-929.
34. Alessi D. R., Cuenda A., Cohen P., Dudley D. T., Saltiel A. R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
35. Leevers S. J., Marshall C. J. Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J. 11:1992;569-574.
36. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory, Cold Spring Harbor. p. 7.43-7.57.
37. Carcamo J., Zentella A., Massague J. Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol. Cell. Biol. 15:1995;1573-1581.
38. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
39. Curran T., MacConnell W. P., van Straaten F., Verma I. M. Structure of the FBJ murine osteosarcoma virus genome: Molecular cloning of its associated helper virus and the cellular homolog of the v-fos gene from mouse and human cells. Mol. Cell. Biol. 3:1983;914-921.
40. Tso J. Y., Sun X. H., Kao T. H., Reece K. S., Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:1985;2485-2502.
41. Påhlman S., Hoehner J. C., Nånberg E., Hedborg F., Fagerström S., Gestblom C., Johansson I., Larsson U., Lavenius E., Örtoft E., Söderholm H. Differentiation and survival influences of growth factors in human neuroblastomas. Eur. J. Cancer. 31A:1995;453-458.
42. Heasley L. E., Johnson G. L. The beta-PDGF receptor induces neuronal differentiation of PC12 cells. Mol. Biol. Cell. 3:1992;545-553.
43. Nguyen T. T., Scimeca J.-C., Filloux C., Peraldi P., Carpentier J.-L., van Obberghen E. Co-regulation of the mitogen-activated protein kinase, extracellular signal-regulated kinase 1 and the 90 kDa ribosomal S6 kinase in PC12 cells. J. Biol. Chem. 268:1993;9803-9810.
44. Hill C. S., Treisman R. Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors. EMBO J. 14:1995;5037-5047.
45. Johnson M. C., Hill C. S., Chawla S., Treisman R., Bading H. Calcium controls gene expression via three distinct pathways that can function independently of the Ras/mitogen-activated protein kinases (ERKs) signaling cascade. J. Neurosci. 17:1997;6189-6202.
46. Karin M., Liu Z.-g., Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:1997;240-246.
47. Hammerling U., Bjelfman C., Påhlman S. Different regulation of N- and c-myc expression during phorbol ester-induced maturation of human SH-SY5Y neuroblastoma cells. Oncogene. 2:1987;73-77.
48. Pang L., Sawada T., Decker S. J., Saltiel A. R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270:1995;13585-13588.
49. Vaillancourt R. R., Heasley L. E., Zamarripa J., Storey B., Valius M., Kazlauskas A., Johnson G. L. Mitogen-activated protein kinase activation is insufficient for growth factor receptor-mediated PC12 cell differentiation. Mol. Cell. Biol. 15:1995;3644-3653.
50. Sano M., Kitajima S. Activation of mitogen-activated protein kinases is not required for the extension of neurites from PC12D cells triggered by nerve growth factor. Brain Res. 785:1998;299-308.
51. 2 is phosphorylated and activated by MAP kinase. Cell. 72:1993;269-278.
52. Sturgill T. W., Ray L. B., Erikson E., Maller J. L. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature. 334:1988;715-718.
53. Alvarez E., Northwood I. C., Gonzalez F. A., Latour D. A., Seth A., Abate C., Curran T., Davis R. J. Pro-Leu-Ser/Thr-Pro is a concensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. J. Biol. Chem. 266:1991;15277-15285.
54. Salghetti S. E., Kim S. Y., Tansey W. P. Destruction of Myc by ubiquitin-mediated proteolysis: Cancer-associated and transforming mutations stabilize Myc. EMBO J. 18:1999;717-726.
55. Davis R. J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:1993;14553-14556.
56. Dhanasekaran N., Premkumar Reddy E. Signaling by dual specificity kinases. Oncogene. 17:1998;1447-1455.
57. Garrington T. P., Johnson G. L. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11:1999;211-218.
58. Kerkhoff E., Rapp U. R. Cell cycle targets of Ras/Raf signalling. Oncogene. 17:1998;1457-1462.
59. Andersson G., Pahlman S., Parrow V., Johansson I., Hammerling U. Activation of the human NPY gene during neuroblastoma cell differentiation: Induced transcriptional activities of AP-1 and AP-2. Cell Growth Differ. 5:1994;27-36.
60. WAF1 is required for survival of differentiating neuroblastoma cells. Mol. Cell Biol. 16:1996;1335-1341.
61. Charles C. H., Abler A. S., Lau L. F. cDNA sequence of a growth factor-inducible immediate early gene and characterization of its encoded protein. Oncogene. 7:1992;187-190.
62. Sun H., Charles C. H., Lau L. F., Tonks N. K. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell. 75:1993;487-493.
63. Misra-Press A., Rim C. S., Yao H., Roberson M. S., Stork P. J. A novel mitogen-activated protein kinase phosphatase. Structure, expression, and regulation. J. Biol. Chem. 270:1995;14587-14596.
64. Camps M., Chabert C., Muda M., Boschert U., Gillieron C., Arkinstall S. Induction of the mitogen-activated protein kinase phosphatase MKP3 by nerve growth factor in differentiating PC12. FEBS Lett. 425:1998;271-276.
65. Sözeri O., Vollmer K., Liyanage M., Frith D., Kour G., Mark G. E. d., Stabel S. Activation of the c-Raf protein kinase by protein kinase C phosphorylation. Oncogene. 7:1992;2259-2262.
66. Kolch W., Heidecker G., Kochs G., Hummel R., Vahidi H., Mischak H., Finkenzeller G., Marme D., Rapp U. R. Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature. 364:1993;249-252.
67. Carroll M. P., May W. S. Protein kinase C-mediated serine phosphorylation directly activates Raf-1 in murine hematopoietic cells. J. Biol. Chem. 269:1994;1249-1256.
68. Marquardt B., Frith D., Stabel S. Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: Reconstitution of the signalling pathway in vitro. Oncogene. 9:1994;3213-3218.
69. Ueda Y., Hirai S., Osada S., Suzuki A., Mizuno K., Ohno S. Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J. Biol. Chem. 271:1996;23512-23519.
70. Schonwasser D. C., Marais R. M., Marshall C. J., Parker P. J. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol. Cell. Biol. 18:1998;790-798.
71. Corbit K. C., Foster D. A., Rich Rosner M. Protein kinase Cδ mediates neurogenic but not mitogenic activation of mitogen-activated protein kinase in neuronal cells. Mol. Cell. Biol. 19:1999;4209-4218.
72. Ball R. L., Albrecht T., Thompson W. C., James O., Carney D. H. Thrombin, epidermal growth factor, and phorbol myristate acetate stimulate tubulin polymerization in quiescent cells: A potential link to mitogenesis. Cell Motil. Cytoskeleton. 23:1992;265-278.
73. Reszka A. A., Seger R., Diltz C. D., Krebs E. G., Fischer E. H. Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc. Natl. Acad. Sci. USA. 92:1995;8881-8885.
74. Bjorkoy G., Perander M., Overvatn A., Johansen T. Reversion of Ras- and phosphatidylcholine-hydrolyzing phospholipase C-mediated transformation of NIH 3T3 cells by a dominant interfering mutant of protein kinase C lambda is accompanied by the loss of constitutive nuclear mitogen-activated protein kinase/extracellular signal-regulated kinase activity. J. Biol. Chem. 272:1997;11557-11565.
75. Khokhlatchev A. V., Canagarajah B., Wilsbacher J., Robinson M., Atkinson M., Goldsmith E., Cobb M. H. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell. 93:1998;605-615.
76. Divecha N., Banfic H., Irvine R. F. The polyphosphoinositide cycle exists in the nuclei of Swiss 3T3 cells under the control of a receptor (for IGF-I) in the plasma membrane, and stimulation of the cycle increases nuclear diacylglycerol and apparently induces translocation of protein kinase C to the nucleus. EMBO J. 10:1991;3207-3214.
77. Leach K. L., Ruff V. A., Jarpe M. B., Adams L. D., Fabbro D., Raben D. M. Alpha-thrombin stimulates nuclear diglyceride levels and differential nuclear localization of protein kinase C isozymes in IIC9 cells. J. Biol. Chem. 267:1992;21816-21822.
78. Leach K. L., Raben D. M. Nuclear localization of protein kinase C. Biochem. Soc. Trans. 21:1993;879-883.
79. Kiley S. C., Parker P. J. Differential localization of protein kinase C isozymes in U937 cells: Evidence for distinct isozyme functions during monocyte differentiation. J. Cell Sci. 108:1995;1003-1016.
80. Neri L. M., Borgatti P., Capitani S., Martelli A. M. Nuclear diacylglycerol produced by phosphoinositide-specific phospholipase C is responsible for nuclear translocation of protein kinase C-α J. Biol. Chem. 273:1998;29738-29744.